Form 8-K - Current report:
SEC Accession No. 0001477932-24-000136
Filing Date
2024-01-12
Accepted
2024-01-11 18:11:25
Documents
15
Period of Report
2024-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avrw_8k.htm   iXBRL 8-K 28422
2 SENIOR SECURED PROMISSORY AND SECURITY AGREEMENT avrw_ex101.htm EX-10.1 24308
  Complete submission text file 0001477932-24-000136.txt   180666

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avrw-20240104.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avrw-20240104_lab.xml EX-101.LAB 14146
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avrw-20240104_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avrw-20240104_pre.xml EX-101.PRE 8922
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avrw-20240104_def.xml EX-101.DEF 2099
9 EXTRACTED XBRL INSTANCE DOCUMENT avrw_8k_htm.xml XML 3503
Mailing Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411
Business Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411 424-273-8675
Avenir Wellness Solutions, Inc. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 24530170
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)